K
Kari Ann Shirey
Researcher at University of Maryland, Baltimore
Publications - 50
Citations - 7210
Kari Ann Shirey is an academic researcher from University of Maryland, Baltimore. The author has contributed to research in topics: TLR4 & Lung injury. The author has an hindex of 28, co-authored 46 publications receiving 5844 citations.
Papers
More filters
Journal ArticleDOI
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines
Peter J. Murray,Judith E. Allen,Subhra K. Biswas,Edward A. Fisher,Derek W. Gilroy,Sergij Goerdt,Siamon Gordon,John A. Hamilton,Lionel B. Ivashkiv,Toby Lawrence,Massimo Locati,Alberto Mantovani,Fernando O. Martinez,Jean-Louis Mege,David M. Mosser,Gioacchino Natoli,Jeroen P. J. Saeij,Joachim L. Schultze,Kari Ann Shirey,Antonio Sica,Jill Suttles,Irina A. Udalova,Jo A. Van Ginderachter,Stefanie N. Vogel,Thomas A. Wynn +24 more
TL;DR: A set of standards encompassing three principles-the source of macrophages, definition of the activators, and a consensus collection of markers to describe macrophage activation are described with the goal of unifying experimental standards for diverse experimental scenarios.
Journal ArticleDOI
The TLR4 antagonist Eritoran protects mice from lethal influenza infection
Kari Ann Shirey,W.Y.C. Lai,Alison J. Scott,Michael M. Lipsky,Pragnesh Mistry,Lioubov M. Pletneva,Christopher L. Karp,Christopher L. Karp,Jaclyn W. McAlees,Theresa L. Gioannini,Theresa L. Gioannini,Jerrold Weiss,Wilbur H. Chen,Robert K. Ernst,Daniel P. Rossignol,Daniel P. Rossignol,Fabian Gusovsky,Jorge C. G. Blanco,Stefanie N. Vogel +18 more
TL;DR: E Eritoran (also known as E5564)-a potent, well-tolerated, synthetic TLR4 antagonist-blocks influenza-induced lethality in mice, as well as lung pathology, clinical symptoms, cytokine and oxidized phospholipid expression, and decreases viral titres as discussed by the authors.
Journal ArticleDOI
Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R|[alpha]|-, TLR4-, and IFN-|[beta]|-dependent
Kari Ann Shirey,Lioubov M. Pletneva,Adam C. Puche,Achsah D. Keegan,Gregory A. Prince,Jorge C. G. Blanco,Stefanie N. Vogel +6 more
TL;DR: New treatment strategies for RSV are suggested that promote AA-Mφ differentiation, which is required for peroxisome proliferator-activated receptorγ expression and regulates IL-4, IL-13,IL-4Rα, and IL-10 expression in response to RSV.
Journal ArticleDOI
Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages.
Nicola M. Heller,Xiulan Qi,Ilkka S. Junttila,Kari Ann Shirey,Stefanie N. Vogel,William E. Paul,Achsah D. Keegan +6 more
TL;DR: H Heller et al. have found a critical difference in the signaling pathways activated by IL-4 and IL-13, which may help in the development of more selective therapies against allergic asthma.
Journal ArticleDOI
Francisella tularensis Live Vaccine Strain Induces Macrophage Alternative Activation as a Survival Mechanism
TL;DR: In this paper, the authors reported that infection with the live vaccine strain (LVS) of the causative agent of tularemia induced TLR2-dependent expression of alternative activation markers that followed the appearance of classically activated markers.